Mai H ElNaggar

Dr. Mai H ElNaggar

Kafrelsheikh University, Kafr ash Shaykh, Egypt
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Fatma M. Abdel BarFatma M. Abdel Bar
Fatma M. Abdel Bar
MAManal A. Alossaimi
Manal A. Alossaimi
Engy ElekhnawyEngy Elekhnawy
Engy Elekhnawy
MAMay Abdullah Abulrahman Alzeer
May Abdullah Abulrahman Alzeer
AKAmal Abo Kamer
Amal Abo Kamer
MEMai H ElNaggar
Mai H ElNaggar
HPLC-UV was used to compare the major constituents of two Pelargonium × hortorum cultivars and Pelargonium sidoides root extract. It revealed the presence of catechin and gallic acid in high concentrations and the absence of umckalin in P. × hortorum root extracts. The antibacterial activity of these extracts was screened against 19 Pseudomonas aeruginosa clinical isolates. P. × hortorum root extracts showed the lowest MIC values (512–1024 µg/mL). This activity was concluded to be attributable to the high concentrations of catechin and gallic acid. The anti-biofilm activity of catechin, gallic acid, and their combination was examined by a crystal violet assay. The combination reduced the percentage of strong and moderate biofilm-forming isolates from 52.63% to 5.26%. The impact on lasI and lasR genes expression using qRT-PCR and simultaneous docking against LasR protein was explored. The combination downregulated lasI and lasR gene expression in eight and six P. aeruginosa isolates, respectively, and showed the greatest docking score. Additionally, the in vivo protection capability of this combination in infected mice showed enhancement in the survival rate. Our study revealed the potential biofilm and quorum-sensing-inhibitory activity of the catechin and gallic acid combination as a novel alternative to inhibit bacterial pathogenicity.

1 February 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MEMai H ElNaggar
Mai H ElNaggar
AMAmira Mira
Amira Mira
Fatma M. Abdel BarFatma M. Abdel Bar
Fatma M. Abdel Bar
Kuniyoshi ShimizuKuniyoshi Shimizu
Kuniyoshi Shimizu
MAMohamed M. Amer
Mohamed M. Amer
Farid BadriaFarid Badria
Farid Badria

11 July 2023 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
MEMai H ElNaggar
Mai H ElNaggar
AEAbdullah Elgazar
Abdullah Elgazar
GGGhada Gamal
Ghada Gamal
SHShimaa M. Hamed
Shimaa M. Hamed
ZEZainab M. Elsayed
Zainab M. Elsayed
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
SARS-CoV-2 pandemic in the end of 2019 led to profound consequences on global health and economy. Till producing successful vaccination strategies, the healthcare sectors suffered from the lack of effective therapeutic agents that could control the spread of infection. Thus, academia and the pharmaceutical sector prioritise SARS-CoV-2 antiviral drug discovery. Here, we exploited previous reports highlighting the anti-SARS-CoV-2 activities of isatin-based molecules to develop novel triazolo-isatins for inhibiting main protease (Mpro) of the virus, a crucial enzyme for its replication in the host cells. Particularly, sulphonamide 6b showed promising inhibitory activity with an IC50= 0.249 µM. Additionally, 6b inhibited viral cell proliferation with an IC50 of 4.33 µg/ml, and was non-toxic to VERO-E6 cells (CC50 = 564.74 µg/ml) displaying a selectivity index of 130.4. In silico analysis of 6b disclosed its ability to interact with key residues in the enzyme active site, supporting the obtained in vitro findings.

28 February 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MEMai H ElNaggar
Mai H ElNaggar
GAghada abdelwahab
ghada abdelwahab
OKOmnia Mohamed Kutkat
Omnia Mohamed Kutkat
MGMohamed GabAllah Abd Al-Fatah Gaballah
Mohamed GabAllah Abd Al-Fatah Gaballah
NCNational Centre
National Centre
AKAshraf Taha Taha Khalil
Ashraf Taha Taha Khalil
Several natural products recovered from a marine-derived Aspergillus niger were tested for their inhibitory activity against SARS CoV-2 in vitro. Aurasperone A (3) was found to inhibit SARS CoV-2 efficiently (IC50 = 12.25 µM) with comparable activity with the positive control remdesivir (IC50 = 10.11 µM). Aurasperone A exerted minimal cytotoxicity on Vero E6 cells (CC50 = 32.36 mM, SI = 2641.5) and it was found to be much safer than remdesivir (CC50 = 415.22 µM, SI = 41.07). To putatively highlight its molecular target, aurasperone A was subjected to molecular docking against several key-viral protein targets followed by a series of molecular dynamics-based in silico experiments that suggested Mpro to be its primary viral protein target. More potent anti-SARS CoV-2 Mpro inhibitors can be developed according to our findings presented in the present investigation.

30 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EMEman Mazyed
Eman Mazyed
Farid BadriaFarid Badria
Farid Badria
MEMai H ElNaggar
Mai H ElNaggar
SMsoha el masry
soha el masry
SHSally Helmy
Sally Helmy
The poor solubility and stability of 6-gingerol (6-G) could hamper its clinical applications. The aim of the current study was to develop a novel ultra-deformable cyclodextrin-functionalized transethoniosomes (CD-TENs) as a promising delivery system for 6-G. Transethoniosomes (TENs) are flexible niosomes (NVs) due to their content of ethanol and edge activators (EAs). CD-functionalized nanoparticles could improve drug solubility and stability compared to the corresponding nanovesicles. 6-G-loaded ethoniosomes (ENs) were formulated by the ethanol injection technique in the presence and absence of EA and CD to explore the impact of the studied independent variables on entrapment efficiency (EE%) and % 6-G released after 24 h (Q24h). According to the desirability criteria, F8 (CD-functionalized transethoniosomal formula) was selected as the optimized formulation. F8 demonstrated higher EE%, permeation, deformability and stability than the corresponding TENs, ENs and NVs. Additionally, F8 showed higher cytotoxic and anti-inflammatory activity than pure 6-G. The synergism between complexation with CD and novel ultra-deformable nanovesicles (TENs) in the form of CD-TENs can be a promising drug delivery carrier for 6-G.

23 September 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MAManal A. Alossaimi
Manal A. Alossaimi
MAMay A. Alzeer
May A. Alzeer
Fatma M. Abdel BarFatma M. Abdel Bar
Fatma M. Abdel Bar
MEMai H ElNaggar
Mai H ElNaggar
This study aimed to establish a validated HPLC-UV analytical method for the determination of gallic acid, catechin, scopoletin, and umckalin in phytoformulations containing P. sidoides. Also, to assess the anti-SARS-CoV-2 effect of P. sidoides and these biomolecules in vitro. An HPLC-UV method was developed and verified by testing the commercial forms, Kalobin® and Umca®. It revealed low detectable scopoletin and high umckalin levels. Pelargonium sidoides exhibited a significant reduction of SARS-CoV-2-induced cytopathic effect in Vero E6 cells (IC50 13.79 μg/mL and selectivity index, SI 6.3), whereas scopoletin showed a remarkable anti-SARS-CoV-2 activity with better selectivity (IC50 17.79 μg/mL and SI 14.22). An in-silico prediction of the drugability indicated that the studied biomolecules are under the acceptable norms of Lipinski’s rule, water-soluble, and showed high GIT absorption and bioavailability. Docking study towards the essential molecular targets for viral replication and entry of SARS-CoV-2 indicated good binding affinity of scopoletin (−6.4 Kcal/mol) towards the interface region between the SARS-CoV-2 spike protein RBD and the ACE2 surface receptor indicating the probability of interference with the viral entry to the human cells and showed H-bonding with His-41 in the active site of the main protease which may explain its high antiviral activity.